美国 · 股市与财经 · Quartz
Foghorn Therapeutics is cutting 40% of its workforce after Eli Lilly ends cancer drug partnership
The companies are scrapping two collaborative cancer programs and don't anticipate any further joint projects
在 Quartz 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (qz.com)




